Absci Reports Business Updates and First Quarter 2026 Financial and Operating ResultsGlobeNewsWire • 05/07/26
Absci to Report Business Updates and First Quarter 2026 Financial and Operating Results on May 7, 2026GlobeNewsWire • 04/23/26
Absci Corporation (ABSI) Presents at 25th Annual Needham Virtual Healthcare Conference TranscriptSeeking Alpha • 04/21/26
Absci to Participate in the 25th Annual Needham Virtual Healthcare ConferenceGlobeNewsWire • 04/08/26
Absci Corporation (ABSI) Reports Q4 Loss, Misses Revenue EstimatesZacks Investment Research • 03/24/26
Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating ResultsGlobeNewsWire • 03/24/26
Absci Corporation (ABSI) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum TranscriptSeeking Alpha • 03/23/26
Absci Corporation (ABSI) Presents at TD Cowen 46th Annual Health Care Conference TranscriptSeeking Alpha • 03/06/26
Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical OfficerGlobeNewsWire • 03/03/26
Absci to Report Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results on March 24, 2026GlobeNewsWire • 02/24/26
Absci Corporation (ABSI) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/15/26
Absci Corporation (ABSI) Discusses ABS-201 Program and Clinical Approach for Androgenetic Alopecia TranscriptSeeking Alpha • 12/11/25
Absci Reports New Human Ex Vivo Data Demonstrating That ABS-201™ Stimulates Hair Growth and Regenerates Stem Cell Niche to Potentially Reverse Follicle MiniaturizationGlobeNewsWire • 12/11/25
Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss ResearchGlobeNewsWire • 12/10/25
ABSI Stock Up on Initiating Dosing in Androgenetic Alopecia StudyZacks Investment Research • 12/05/25
Absci Announces First Participants Dosed in Phase 1/2a HEADLINE™ Trial of AI-Designed Antibody ABS-201™ for Androgenetic AlopeciaGlobeNewsWire • 12/04/25
Absci Corporation (ABSI) Presents at Jefferies London Healthcare Conference 2025 TranscriptSeeking Alpha • 11/22/25
Absci Reports Business Updates and Third Quarter 2025 Financial and Operating ResultsGlobeNewsWire • 11/12/25